LFCR Q2 2020 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$143M+14.2% YoY

Gross Profit

$16M10.9% margin

Operating Income

-$6M-4.2% margin

Net Income

-$7M-4.7% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+2.8%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$16M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$560M

Total Liabilities

$301M

Stockholders' Equity

$259M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$143M	$125M	+14.2%
Gross Profit	$16M	$17M	-6.5%
Operating Income	-$6M	-$606,000	-896.0%
Net Income	-$7M	-$584,000	-1054.1%